The promotion of VSV oncolysis by vorinostat in prostate cancer cells was traced back to the reversible induction of NF-κB signaling through increased acetylation, nuclear translocation and DNA binding activity of the NF-κB subunit RELA/p65 [142]. This evidence concerns the gene NFKB1 and prostate cancer.